Despite opening today lower at $3.46, Evogene Ltd. (NASDAQ:EVGN) has moved up. Is a breakout in sight?
Evogene’s Lavie Bio Hires Russ Putland as Vice President Commercial
Lavie Bio, an ag-biologicals company focusing on improving food quality, sustainability, and agriculture productivity through the introduction of microbiome-based products.
Lavie Bio is a subsidiary of Evogene Ltd
Russ Putland last stint was with DuPont crop protection in sales department
Russ’s experience includes working directly with farmers, retailers, distribution channels and manufacturers and is thus the right fit for Lavie Bio
Russ will be responsible for commercial strategy and execution, focusing on establishing relationships and partnerships with strategic and channel partners, driving revenue from ag-biological bio-stimulant and bio-pesticide product lines.
“I am very happy with the addition of Russ to the Lavie Bio management team. No doubt that his experience and leadership will be a great addition to the Lavie family and drive our exciting journey of taking Lavie Bio to its next phase – commercialization of our product pipeline,” commented CEO Ido Dor, Lavie Bio.
Evogene (EVGN) is up $0.051 or 0.435% to $3.49. Trading at low volume of 61.54K compared to its 30-day average of 556K shares. The stock has been trading in a narrow range of $3.46 – $3.57. If the rally continue EVGN can breach its 50-day moving average of $4.1217. Keep an eye on pivot points 3.536 3.603 above and 3.336 3.403 below.